Benjamin Carpentier

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

9-Year Serial CMR Monitoring of Cardiac AL Amyloidosis Regression After Teclistamab.

9-Year Serial CMR Monitoring of Cardiac AL Amyloidosis Regression After Teclistamab.

Journal: JACC. Case reports

Published: April 16, 2026

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.

Journal: Leukemia

Published: April 14, 2026

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Journal: HemaSphere

Published: November 26, 2025

High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).

High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).

Journal: BMJ open

Published: September 18, 2025

Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study.

Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study.

Journal: Blood cancer journal

Published: August 06, 2025

Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Double-Blind Controlled Randomized Clinical Trial.

Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Double-Blind Controlled Randomized Clinical Trial.

Journal: American journal of respiratory and critical care medicine

Published: April 10, 2025

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

Journal: European journal of haematology

Published: March 27, 2025

Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.

Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.

Journal: Blood cancer journal

Published: January 21, 2025

MMS22L is a novel key actor of normal and pathological erythropoiesis.

MMS22L is a novel key actor of normal and pathological erythropoiesis.

Journal: HemaSphere

Published: November 04, 2024

Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis.

Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 11, 2024

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.

Journal: Annals of the rheumatic diseases

Published: February 06, 2024

Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS-CoV-2.

Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS-CoV-2.

Journal: Influenza and other respiratory viruses

Published: March 03, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026